Johnson & Johnson (J&J) has successfully challenged two talc verdicts and has mitigated nearly $500 million in damages in less than a week. The largest verdict to date, the $417 million Echevarria verdict, was reversed and a new trial has been ordered. This decision comes at the heels of J&J convincing a St. Louis appeals court to vacate a separate $72 million verdict.
Superior Court Judge Maren Nelson concluded that the evidence presented during Echevaria’s trial didn’t support the large verdict. Judge Nelson wrote that…
Continue reading...
Litigation
Continue reading...
- Eli Lilly, Others Urge 6th Circ. To Toss Darvocet Appeal (subscription required)
- McNeil Asks Pa. Appeals Court to Boot $10M Motrin Verdict (subscription required)
- J&J to Pay $4B to Settle Hip Implant Suits (subscription required)
- J&J Trying to Back Out of 77 Risperdal Deals, Plaintiffs Say (subscription required)
- Birth Defect Lawyers in Effexor MDL Assigned to Leadership Roles
- Final Bard Avaulta Vaginal Mesh Bellweather Trial Set for Dec. 3
- Stryker Rejuvenate Hip Attorneys Assigned to leadership Positions in MDL
Continue reading...
Litigation
Continue reading...
- Pfizer Opposes Centralization of Lipitor Cases for Diabetic Women
- J&J Settles Risperdal Lawsuit Over Illegal Marketing for $2.2B
- High Court Won’t Hear Okla. Appeal Over Abortion-Drug Law (subscription required)
- Supreme Court Asked to Take Up Lupron Labeling Suit (subscription required)
- Granuflo Dialysate Lawsuits Conference to Discuss Pending Motions
- Intuitive Surgical Insurance for da Vinci Robot Lawsuits Challenged
- Pfizer Concealed Zoloft Ineffectiveness, Louisiana Lawsuit Claims
- Topomaz Birth Defect Lawsuit Results in $4M Jury Award
- Lipitor Diabetes Risk for Women was
Continue reading...
Last week, Johnson and Johnson settled a bellweather case that was scheduled to commence on October 15, 2013 in California. Plaintiff in that action claimed that his injuries were allegedly caused by the company’s ASR metal-on-metal hip implants. The case is Ottman v. Johnson & Johnson, No. CGC-12-517391, in California Superior Court. The terms of the settlement are confidential.
Another bellweather trial involving the company’s hip implants is scheduled to take place in early 2014 in Los Angeles.
Johnson & Johnson and its subsidiary DePuy…
Continue reading...
Continue reading...